Previous Tx in Metastatic Melanoma May Cut Response to ACT TIL

THURSDAY, Aug. 19, 2021 -- Previous treatment with anti-programmed cell death-1 (aPD-1) therapy or targeted molecular therapy is associated with a lower objective response rate to adoptive cell transfer (ACT) of autologous tumor-infiltrating...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news